BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14659045)

  • 1. In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Takahashi T; Kawabe T; Okazaki Y; Itoh C; Noda K; Tajima M; Satoh M; Goto M; Mitsui Y; Tahara H; Ide T; Furuichi Y; Sugimoto M
    DNA Cell Biol; 2003 Nov; 22(11):727-35. PubMed ID: 14659045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Sugimoto M; Tahara H; Ide T; Furuichi Y
    Cancer Res; 2004 May; 64(10):3361-4. PubMed ID: 15150084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Okubo M; Tsurukubo Y; Higaki T; Kawabe T; Goto M; Murase T; Ide T; Furuichi Y; Sugimoto M
    Cancer Genet Cytogenet; 2001 Aug; 129(1):30-4. PubMed ID: 11520562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immortalization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity.
    Kataoka H; Tahara H; Watanabe T; Sugawara M; Ide T; Goto M; Furuichi Y; Sugimoto M
    Differentiation; 1997 Dec; 62(4):203-11. PubMed ID: 9503605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
    Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
    J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the potential malignancy of Epstein-Barr virus (EBV)-infected B cells in AIDS-related disorders.
    Roncella S; Caretto P; Forni G; Cutrona G; Verde A; Ramarli D; de Celle PF; Foá R; Sessarego M; Pistoia V
    Cancer Detect Prev; 1990; 14(3):325-9. PubMed ID: 2167168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of EBV-Infected Lymphoblastoid Cell Lines.
    Nagy N
    Methods Mol Biol; 2017; 1532():57-64. PubMed ID: 27873266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained viral activity of epstein-Barr virus contributes to cellular immortalization of lymphoblastoid cell lines.
    Jeon JP; Nam HY; Shim SM; Han BG
    Mol Cells; 2009 Feb; 27(2):143-8. PubMed ID: 19277495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human B-lymphoid cell lines.
    Nilsson K
    Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV transformation overrides gene expression patterns of B cell differentiation stages.
    Siemer D; Kurth J; Lang S; Lehnerdt G; Stanelle J; Küppers R
    Mol Immunol; 2008 Jun; 45(11):3133-41. PubMed ID: 18430472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Jeon JP; Shim SM; Nam HY; Baik SY; Kim JW; Han BG
    Cancer Genet Cytogenet; 2007 Mar; 173(2):122-30. PubMed ID: 17321327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines.
    Sugimoto M; Ide T; Goto M; Furuichi Y
    Mech Ageing Dev; 1999 Feb; 107(1):51-60. PubMed ID: 10197788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
    Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
    Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WRN gene and other genetic factors affecting immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Sugimoto M; Tahara H; Okubo M; Kobayashi T; Goto M; Ide T; Furuichi Y
    Cancer Genet Cytogenet; 2004 Jul; 152(2):95-100. PubMed ID: 15262425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the oncogenic potential of Epstein-Barr-virus (EBV)-infected B cells in AIDS-related disorders.
    Roncella S; Caretto P; Forni G; Cutrona G; Verde A; Ramarli D; di Celle PF; Foà R; Sessarego M; Pistoia V
    Int J Cancer Suppl; 1989; 4():78-82. PubMed ID: 2553627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.
    Maruo S; Wu Y; Ishikawa S; Kanda T; Iwakiri D; Takada K
    Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19500-5. PubMed ID: 17159137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Lee DH; Park KS; Kong ID; Kim JW; Han BG
    BMC Immunol; 2006 Sep; 7():22. PubMed ID: 16970829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations and activation-induced cytidine deaminase (AID) expression in established rheumatoid factor-producing lymphoblastoid cell line.
    Gil Y; Levy-Nabot S; Steinitz M; Laskov R
    Mol Immunol; 2007 Jan; 44(4):494-505. PubMed ID: 16574227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.